Peakdale Molecular Ltd. Announces Innovative On-Site Research Collaboration
Published: Feb 01, 2010
Derbyshire, England – February 1st, 2010: Peakdale Molecular Limited (“Peakdale”), a leading research Services Company headquartered in the UK, announced today that it has entered into an agreement with Pfizer Limited. Peakdale Molecular, through its wholly-owned subsidiary Peakdale Chemistry Services Ltd, will supply custom synthetic chemistry services to Pfizer onsite at the company’s laboratories in Sandwich, UK. This will involve building a team of more than 50 synthetic chemists at the Pfizer Research site in Kent, supplementing the main Peakdale facility in Derbyshire, which employs 90 synthetic chemists. This facility will not only provide on site chemistry resources for Pfizer, but also provide a resource for other developing companies in the vicinity. The presence of a world class chemistry development facility will add to the attraction of the Sandwich site as an innovation hub for the region. Dr Tony Wood, Vice President, Pfizer World-Wide Medicinal Chemistry said: “Synthetic organic chemistry sits at the centre of drug discovery. This collaboration will allow Pfizer to continue to develop a strong community of experienced synthetic chemists within its facilities and enhance the overall culture of synthetic chemistry at the Sandwich site." “The positioning of Peakdale chemists close to the core of our research operations gives a unique opportunity in this outsourced space,” said David Roblin, Sandwich Head of Research and Site Director of Pfizer Sandwich Laboratories. “In addition, this move begins to enhance the utilisation of the real estate assets we have at Sandwich. I hope this is just the first example we will see in this vein.” “This is a great opportunity for Peakdale to contribute to Pfizer’s success as the Pharmaceutical Industry seeks to become more efficient and responsive to the rapidly changing environment of drug discovery”, said Ray Fisher, PhD, Founder and CEO, Peakdale Molecular Limited. “We are extremely pleased that Pfizer has chosen us to promote this new initiative and see this model as one way to bring the entrepreneurial spirit of smaller companies to synergise with the expertise and know-how of an established world leader.” About Pfizer Ltd. Working together for a healthier world™ Pfizer Ltd. is a leading global pharmaceutical company. At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world’s leading Biopharmaceutical Company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more about our commitments, please visit us at www.pfizer.com. About Peakdale Molecular Limited Peakdale Molecular is based in Chapel-en-le Frith, Derbyshire and has been established as a provider of research services to the pharmaceutical and biotechnology industry since 1992. In state of the art laboratories with over 90 chemists it continues to provide problem solving expertise from discovery to scale up across Europe and the USA. For more information on Peakdale Molecular, please visit www.peakdale.co.uk.